Circulating miRNA Profiles in Patients with Metabolic Syndrome

被引:428
作者
Karolina, Dwi Setyowati [1 ]
Tavintharan, Subramaniam [2 ]
Armugam, Arunmozhiarasi [1 ]
Sepramaniam, Sugunavathi [1 ]
Pek, Sharon Li Ting [2 ]
Wong, Michael T. K. [2 ]
Lim, Su Chi [2 ]
Sum, Chee Fang [2 ]
Jeyaseelan, Kandiah [1 ,3 ]
机构
[1] Natl Univ Singapore, Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117597, Singapore
[2] Khoo Teck Puat Hosp, Ctr Diabet, Singapore 768828, Singapore
[3] Monash Univ, Fac Med Nursing & Hlth Sci, Sch Biomed Sci, Dept Anat & Dev Biol, Clayton, Vic 3800, Australia
基金
英国医学研究理事会; 新加坡国家研究基金会;
关键词
EXPRESSION; MICRORNAS; BIOMARKERS; DIAGNOSIS;
D O I
10.1210/jc.2012-1996
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Context: Coordinated interplay of dysregulated microRNAs in isolated metabolic disorder is implicated in the pathogenesis of metabolic syndrome. Objective: The objective of the study was to characterize microRNA expression in the blood and exosomes of individuals with metabolic syndrome and compare them with those manifesting one of the metabolic vascular risk factors (type 2 diabetes, hypercholesterolemia, or hypertension). Research Design/Setting/Participants: Atotal of 265 participants were recruited in a health screening and characterized into distinct groups as follows: 1) healthy controls (n = 46); 2) metabolic syndrome (n = 50); 3) type 2 diabetes (n = 50); 4) hypercholesterolemia (n = 89); and 5) hypertension (n = 30). Total RNA was subjected to microRNA profiling, and a panel of significantly dysregulated microRNAs was validated using quantitative PCR. Main Outcome Measures: Analysis of profiling data characterized unique pools of miRNAs that could categorize the different risk factors of metabolic syndrome. Results: We have identified miR-197, miR-23a, and miR-509-5p as potential contributors of dyslipidemia in metabolic syndrome (correlation with body mass index; P = 0.029, 0.021, and 0.042, respectively) and miR-130a and miR-195 as contributors of hypertension (correlation with blood pressure; P = 0.019 and 0.045, respectively). A plausible association of miR-27a and miR-320a with metabolic syndrome and type 2 diabetes patients has also been found because these miRNAs remained dysregulated in both cases (correlation with fasting glucose; P = 0.010 and 0.016, respectively). Conclusions: Significant dysregulation of seven candidate microRNAs has been found to be associated with risks involved in the manifestation of metabolic syndrome. (J Clin Endocrinol Metab 97: E2271-E2276, 2012)
引用
收藏
页码:E2271 / E2276
页数:6
相关论文
共 20 条
[1]
Complications of Laparoscopic Roux-en-Y Gastric Bypass [J].
Al Harakeh, Ayman B. .
SURGICAL CLINICS OF NORTH AMERICA, 2011, 91 (06) :1225-+
[2]
Interleukin-6 Modulates the Expression of the Bone Morphogenic Protein Receptor Type II Through a Novel STAT3-microRNA Cluster 17/92 Pathway [J].
Brock, Matthias ;
Trenkmann, Michelle ;
Gay, Renate E. ;
Michel, Beat A. ;
Gay, Steffen ;
Fischler, Manuel ;
Ulrich, Silvia ;
Speich, Rudolf ;
Huber, Lars C. .
CIRCULATION RESEARCH, 2009, 104 (10) :1184-U139
[3]
Molecular therapy of obesity and diabetes by a physiological autoregulatory approach [J].
Cao, Lei ;
Lin, En-Ju D. ;
Cahill, Michael C. ;
Wang, Chuansong ;
Liu, Xianglan ;
During, Matthew J. .
NATURE MEDICINE, 2009, 15 (04) :447-454
[4]
Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases [J].
Chen, Xi ;
Ba, Yi ;
Ma, Lijia ;
Cai, Xing ;
Yin, Yuan ;
Wang, Kehui ;
Guo, Jigang ;
Zhang, Yujing ;
Chen, Jiangning ;
Guo, Xing ;
Li, Qibin ;
Li, Xiaoying ;
Wang, Wenjing ;
Zhang, Yan ;
Wang, Jin ;
Jiang, Xueyuan ;
Xiang, Yang ;
Xu, Chen ;
Zheng, Pingping ;
Zhang, Juanbin ;
Li, Ruiqiang ;
Zhang, Hongjie ;
Shang, Xiaobin ;
Gong, Ting ;
Ning, Guang ;
Wang, Jun ;
Zen, Ke ;
Zhang, Junfeng ;
Zhang, Chen-Yu .
CELL RESEARCH, 2008, 18 (10) :997-1006
[5]
Circulating MicroRNAs Novel Biomarkers and Extracellular Communicators in Cardiovascular Disease? [J].
Creemers, Esther E. ;
Tijsen, Anke J. ;
Pinto, Yigal M. .
CIRCULATION RESEARCH, 2012, 110 (03) :483-495
[6]
Gavin JR, 1997, DIABETES CARE, V20, P1183
[7]
Differential miRNA Expression in Omental Adipose Tissue and in the Circulation of Obese Patients Identifies Novel Metabolic Biomarkers [J].
Heneghan, H. M. ;
Miller, N. ;
McAnena, O. J. ;
O'Brien, T. ;
Kerin, M. J. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (05) :E846-E850
[8]
MicroRNA expression in the blood and brain of rats subjected to transient focal ischemia by middle cerebral artery occlusion [J].
Jeyaseelan, Kandiah ;
Lim, Kai Ying ;
Armugam, Arunmozhiarasi .
STROKE, 2008, 39 (03) :959-966
[9]
MicroRNA 144 Impairs Insulin Signaling by Inhibiting the Expression of Insulin Receptor Substrate 1 in Type 2 Diabetes Mellitus [J].
Karolina, Dwi Setyowati ;
Armugam, Arunmozhiarasi ;
Tavintharan, Subramaniam ;
Wong, Michael T. K. ;
Lim, Su Chi ;
Sum, Chee Fang ;
Jeyaseelan, Kandiah .
PLOS ONE, 2011, 6 (08)
[10]
MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-β-induced collagen expression via inhibition of E-box repressors [J].
Kato, Mitsuo ;
Zhang, Jane ;
Wang, Mei ;
Lanting, Linda ;
Yuan, Hang ;
Rossi, John J. ;
Natarajan, Rama .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (09) :3432-3437